Amylyx Pharmaceuticals Inc (AMLX)

04:35 AM

Amylyx Pharmaceuticals (AMLX) to Release Earnings on Thursday - MarketBeat

04:35 AM

02:09 AM

Vanguard Group Inc's Strategic Reduction in Amylyx Pharmaceutica - GuruFocus.com

02:09 AM

Nov 04, 2024

There's No Escaping Amylyx Pharmaceuticals, Inc.'s (NASDAQ:AMLX) Muted Revenues Despite A 81% Share Price Rise - Simply Wall St

Nov 04, 2024

Nov 04, 2024

Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 - StockTitan

Nov 04, 2024

Nov 03, 2024

abrdn plc Buys 1,853,995 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat

Nov 03, 2024

Nov 01, 2024

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Nov 01, 2024

Oct 30, 2024

Levi & Korsinsky Reminds Amylyx Investors of the Pending Class A - GuruFocus.com

Oct 30, 2024

Oct 28, 2024

Short Interest in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Declines By 21.1% - MarketBeat

Oct 28, 2024

Oct 25, 2024

Perceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals Inc - Yahoo Finance

Oct 25, 2024

Oct 24, 2024

Amylyx upgraded to buy by BofA on hypoglycemia drug potential - MSN

Oct 24, 2024

Oct 23, 2024

BofA upgrades Amylyx stock to Buy rating By Investing.com - Investing.com Australia

Oct 23, 2024

Oct 23, 2024

BofA upgrades Amylyx stock to Buy rating - Investing.com

Oct 23, 2024

Oct 23, 2024

Amylyx Pharmaceuticals (NASDAQ:AMLX) Upgraded to Buy by Bank of America - MarketBeat

Oct 23, 2024

Oct 22, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Acti - GuruFocus.com

Oct 22, 2024

Oct 19, 2024

Amylyx Pharmaceuticals reports results from pancreatic disease treatment trial - MSN

Oct 19, 2024

Oct 19, 2024

Amylyx Pharmaceuticals (AMLX): Leading Nano Cap in Neurodegenerative Disease Treatments - Insider Monkey

Oct 19, 2024

Oct 18, 2024

Why Amylyx Pharmaceuticals Stock Was So Healthy This Week - MSN

Oct 18, 2024

Oct 18, 2024

Amylyx shares reiterate Buy rating on trial data - Investing.com

Oct 18, 2024

Oct 18, 2024

Amylyx shares reiterate Buy rating on trial data By Investing.com - Investing.com UK

Oct 18, 2024

Oct 18, 2024

Amylyx Pharmaceuticals (NASDAQ:AMLX) Receives "Buy" Rating from HC Wainwright - MarketBeat

Oct 18, 2024

Oct 18, 2024

H.C. Wainwright maintains Buy rating on Amylyx shares on trial data - Investing.com

Oct 18, 2024

Oct 18, 2024

H.C. Wainwright maintains Buy rating on Amylyx shares on trial data By Investing.com - Investing.com UK

Oct 18, 2024

Oct 18, 2024

Amylyx’s AMX0035 shows promise in Phase II Wolfram syndrome trial - Clinical Trials Arena

Oct 18, 2024

Oct 18, 2024

PTC rebuffed again by EMA; Novartis licenses China-based biotech’s cancer drug - Yahoo Finance

Oct 18, 2024

Oct 18, 2024

Leerink maintains Market Perform rating on Amylyx stock on new data - Investing.com

Oct 18, 2024

Oct 18, 2024

Leerink maintains Market Perform rating on Amylyx stock on new data By Investing.com - Investing.com South Africa

Oct 18, 2024

Oct 17, 2024

Amylyx reports positive trial results for Wolfram syndrome treatment - Investing.com India

Oct 17, 2024

Oct 17, 2024

Amylyx reports positive trial results for Wolfram syndrome treatment By Investing.com - Investing.com South Africa

Oct 17, 2024

Oct 17, 2024

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome - Business Wire

Oct 17, 2024

Oct 15, 2024

Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024 - BioSpace

Oct 15, 2024

Oct 15, 2024

Amyotrophic Lateral Sclerosis Market 2034 | Mitsubishi Tanabe - openPR

Oct 15, 2024

Oct 15, 2024

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Shares Sold by Millennium Management LLC - MarketBeat

Oct 15, 2024

Oct 11, 2024

Deutsche Bank Initiates Coverage of Amylyx Pharmaceuticals (AMLX) with Buy Recommendation - MSN

Oct 11, 2024

Oct 07, 2024

Brokerages Set Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Target Price at $17.60 - MarketBeat

Oct 07, 2024

Oct 06, 2024

American Century Companies Inc. Reduces Stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat

Oct 06, 2024

Oct 04, 2024

AQR Capital Management LLC Acquires 3,224,454 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - MarketBeat

Oct 04, 2024

Oct 03, 2024

Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm - Marketscreener.com

Oct 03, 2024

Oct 03, 2024

Amylyx Pharmaceuticals executive sells over $27k in company stock - Investing.com India

Oct 03, 2024

Oct 03, 2024

Amylyx Pharmaceuticals executive sells over $27k in company stock By Investing.com - Investing.com Canada

Oct 03, 2024

Oct 03, 2024

Amylyx Pharmaceuticals executive sells over $36k in company stock - Investing.com

Oct 03, 2024

Oct 02, 2024

Amylyx Pharmaceuticals executive sells over $36k in company stock By Investing.com - Investing.com Australia

Oct 02, 2024

Oct 02, 2024

Insider Selling: Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Insider Sells 11,442 Shares of Stock - MarketBeat

Oct 02, 2024

Oct 02, 2024

Amylyx Pharmaceuticals CEO sells over $59k in stock By Investing.com - Investing.com South Africa

Oct 02, 2024

Oct 02, 2024

Amylyx Co-CEO sells over $59,000 in company stock By Investing.com - Investing.com South Africa

Oct 02, 2024

Oct 02, 2024

Amylyx Pharmaceuticals CEO sells over $59k in stock - Investing.com

Oct 02, 2024

Oct 02, 2024

Amylyx Co-CEO sells over $59,000 in company stock - Investing.com

Oct 02, 2024

Oct 01, 2024

Amylyx Pharmaceuticals Navigates Shift to Smaller Reporting Status: Impacts on Investor Relations and Stock Volatility - TipRanks

Oct 01, 2024

Sep 30, 2024

Amyotrophic Lateral Sclerosis Treatment Market is Booming with - openPR

Sep 30, 2024

Sep 30, 2024

Almitas Capital LLC Makes New Investment in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World

Sep 30, 2024